RUNX1T1 and acute myeloid leukemia: Electroporation of AML cells with RUNX1/ETO siRNA prior to transplantation enhanced the survival of leukaemic mice, providing a proof for the concept that reducing the fusion expression might be therapeutically beneficial [8].